Skip to main content
. 2023 Mar 1;19(3):529–538. doi: 10.5664/jcsm.10382

Table 2.

Demographics, clinical, and polysomnographic data per positional group.

Variable spOSA siOSA Lateral PP NPP
N (%) 257 (29.8) 293 (34.0) 35 (4.1) 276 (32.1)
Sex, n (%)
 Male 156 (60.7)* 149 (50.9) 13 (37.1) 143 (52.9)
Race/ethnicity, n (%)
 White, Caucasian 96 (37.4) 122 (41.6) 15 (42.9) 86 (31.2)
 Chinese American 34 (13.2) 42 (14.3) 1 (2.9) 27 (9.8)
 Black, African American 64 (24.9) 67 (22.9) 12 (34.3) 90 (32.6)
 Hispanic 63 (24.5) 62 (21.1) 7 (20.0) 73 (27.4)
Cigarette smoking, n (%)
 Never 124 (48.2) 173 (48.8) 13 (37.1) 120 (43.5)
 Former 109 (42.4) 132 (45.1) 18 (51.4) 142 (51.4)
 Current 23 (8.9) 17 (5.8) 3 (8.6) 14 (5.1)
 None 0 (0) 1 (0.3) 1 (2.9) 0 (0.0)
Hypertension, n (%)
 No 104 (40.5) 149 (50.9)* 11 (31.4) 96 (34.8)
 Yes 153 (59.5) 144 (49.1)* 23 (65.7) 180 (65.2)
 None 0 (0) 0 (0) 1 (2.9) 1 (0.3)
Asthma, n (%)
 No 250 (97.3) 283 (96.6) 32 (91.4) 262 (94.9)
 Yes 6 (2.3) 9 (3.1) 2 (8.6) 14 (5.1)
 Don’t know 0 (0.0) 0 (0) 0 (0) 0 (0)
 None 1 (0.4) 1 (0.3) 0 (0) 0 (0)
ESS, n (%)
 Normal (0–10) 209 (81.3) 263 (89.8) 29 (88.4) 228 (82.6)
 Mild (11–14) 29 (11.3) 23 (7.8) 3 (8.6) 36 (13.0)
 Moderate (15–17) 11 (4.3) 3 (1.0) 2 (5.7) 8 (2.9)
 Severe (18–24) 4 (1.6) 2 (07.) 1 (2.9) 2 (0.7)
 None 4 (1.6) 2 (0.7) 0 (0) 2 (0.7)
Emphysema or COPD,** n (%)
 No 250 (97.3) 288 (98.3) 34 (97.1) 270 (97.8)
 Yes 6 (2.3) 4 (1.4) 1 (2.9) 5 (1.8)
 Don’t know 0 (0) 1 (0.3) 0 (0) 1 (0.4)
 None 1 (0.4) 0 (0) 0 (0) 0 (0.0)
Atrial fibrillation, n (%)
 No 253 (98.4) 289 (98.7) 34 (97.1) 271 (98.2)
 Yes 3 (1.2) 1 (0.3) 0 (0) 4 (1.4)
 None 1 (0.4) 3 (1.0) 1 (2.9) 1 (0.4)
AHI, median (IQR), events/h 19.9 (18.2)* 9.4 (6.4)* 11.2 (8.6)* 17.2 (22.6)*
 Supine 39.9 (32.5)* 18.6 (16.8)* 3.8 (4.6)* 19.9 (27.0)*
 Nonsupine 9.8 (9.0)* 1.8 (2.7)* 13.7 (13.3)* 16.0 (20.2)*
 REM 5.1 (4.6)* 3.2 (3.8)* 6.2 (4.6) 5.9 (5.4)*
 NREM 14.8 (15.8)* 5.8 (6.4)* 4.0 (4.7)* 10.6 (21.4)*
Demographics, median (IQR)
 Age, y 67 (14) 67 (15) 66 (11.5) 68 (14)
 BMI, kg/m2 29.0 (5.9)* 26.9 (5.2)* 31.4 (4.9)* 30.5 (8.0)*
No. of events, median (IQR)
 Apneas 24 (44.0) 12.0 (27.0) 10.0 (22.5) 15.5 (44)
 Hypopneas 92.0 (77.0) 44.0 (33.0) 51.0 (57.0) 80.0 (89.5)
Longest event, median (IQR)
 Apnea, s 41.4 (25.5)* 34.3 (20.9)* 30.7 (18.9) 37.7 (25.5)
 Hypopnea, s 49.6 (19.2) 46.9 (25.2) 44.6 (30.3) 46.6 (18.7)
Sleep efficiency, median (IQR)
 Average, min 91.0 (5.0) 92.1 (4.6) 91.4 (3.5) 91.5 (4.5)
 Standard deviation, min 2.5 (1.9) 2.3 (1.7) 2.4 (1.5) 2.4 (1.6)
Body shape, median (IQR)
 Waist, cm 100 (16.0)* 95.9 (14.5)* 103.3 (18.6) 104 (18.2)*
 Hip, cm 104.2 (13.0)* 101.8 (11.0)* 109.5 (10.3)* 108.5 (18.5)*
TST, median (IQR), h 6.3 (1.7) 6.3 (1.2) 6.4 (1.4) 6.3 (1.3)
 Supine 2.2 (2.2)* 3.1 (2.4)* 1.5 (1.6)* 2.3 (2.5)*
 Nonsupine 3.9 (2.2)* 3.0 (2.3)* 4.7 (2.3)* 3.6 (2.2)*
 REM 1.1 (0.7) 1.2 (0.6)* 1.2 (0.7) 1.1 (0.6)
 NREM 5.1 (1.4) 5.0 (1.1) 5.2 (1.2) 5.3 (1.2)

Demographics, clinical and polysomnographic data of 861 MESA patients with OSA, divided into 4 groups: spOSA, siOSA, Lateral PP, and NPP. *Statistically significantly different between the other 2 or 3 OSA phenotype groups. Statistical difference was computed using Kruskal-Wallis H-test for independent samples, and significance was considered for P values < .05. **Self-reported. AHI = apnea-hypopnea index, BMI = body mass index, COPD = chronic obstructive pulmonary disease, ESS = Epworth Sleepiness Scale, IQR = interquartile range, MESA = Multi-Ethnic Study of Atherosclerosis, NPP = non-positional patients, NREM = non–rapid eye movement, OSA = obstructive sleep apnea, PP = positional patients, REM = rapid eye movement, siOSA = supine isolated OSA, spOSA = supine predominant OSA, TST = total sleep time.